Jazz Pharmaceuticals plc JAZZ

RE:Cannabinoid Pharma

[alleyesonme]

According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that depends on the occurrence of certain other events.....medipharm labs is in an undisclosed partnership on a ANDA for the epidiolex generic...president stated earlier in the year they are preparing for launch..I think pagadis is the partner ....medipharm has a drug establishment license, a FDA drug master file with the FDA for cannabidol, a successful FDA site audit, DEA import permits (the only Canadian Corp to achieve this) and a high capacity GMP facility....it's very interesting Jazz has approved this generic...they must have a licensing agreement or some other beneficial arrangement...https://www.greenmarketreport.com/judge-not-swayed-in-patent-battle-over-epidiolex-patents/.        https://stockhouse.com/news/press-releases/2023/08/01/medipharm-labs-makes-first-delivery-of-cannabis-clinical-trial-material-to-us